Article
Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples.
Human pathology - 1 Aug 2013
Fan Xiangshan, Liu Biao, Xu Haodong, Yu Bo, Shi Shanshan, Zhang Jin, Wang Xuan, Wang Jiandong, Lu Zhenfeng, Ma Henghui, Zhou Xiaojun
Abstract excerpt
Mutation analysis of epidermal growth factor receptor (EGFR) is essential in determining the therapeutic strategy for lung adenocarcinoma. Immunohistochemical (IHC) staining with EGFR mutation-specific antibodies of del E746-A750 in exon 19 and L858R in exon 21 has been evaluated in resection specimens in a few studies but rarely in biopsy samples. A total of 169 cases (78 biopsies and 91 resected specimens) of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
